甲状腺功能正常的桥本甲状腺炎患者临床症状及证型分布规律

doi:10.20047/j.issn1673-7210.2022.29.31

Abstract
Figure/Table
References (28)
Related Citation (15)

Download: PDF (1474 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the distribution of clinical symptoms and syndrome in enthyroid hashimoto thyroiditis (HT) patients. Methods Enthyroid HT patients treated in the Department of Thyroid, Dongzhimen Hospital and Sun Simiao Hospital of Beijing University of Chinese Medicine from December 2020 to December 2021 were selected, the four diagnosis information of them was collected by traditional Chinese medicine symptom scale, and statistical analysis and cluster analysis were carried out by SPSS software. Results A total of 267 cases of enthyroid HT were collected in this study. After standardizing the name, 52 traditional Chinese medicine symptoms and signs with a frequency of more than 10% were screened. The most common symptoms were irritability (73.03%), fatigue (69.66%), memory loss (62.17%), anxiety (61.80%), pharyngeal foreign body sensation (54.68%), dry mouth (51.31%), palpitation (50.56%), depression and sadness (50.19%), the most common sign was goiter (68.16%); eight tongue signs with frequency greater than 10% were screened, the most common tongue signs were white fur (71.16%), thin fur (61.05%) and teeth-printed tongue (31.09%); three pulse types with frequency greater than 10% were screened,the most common pulse was stringy pulse (34.83%). After cluster analysis, three traditional Chinese medicine syndrome types were obtained: stagnation of liver qi, phlegm-dampness due to spleen deficiency; Stagnation of heat in liver channel, deficiency of spleen and phlegm coagulation; deficiency of spleen and kidney, syndrome of deficiency of both yin and Yang. Conclusion This study shows that enthyroid Hashimoto thyroiditis can be divided into three types: stagnation of liver qi, phlegm-dampness due to spleen deficiency at the beginning; the middle stage of the disease is stagnation of liver qi, syndrome of phlegm-dampness due to spleen deficiency; the disease is characterized by deficiency of spleen and syndrome of kidney and deficiency of both yin and Yang.

Key words： Hashimoto thyroiditis Syndrome type Cluster analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Shoujing1 QI Shuo2 SHANG Jianwei3 HU Rui3 CHEN Xiaoheng3 YAO Simiao1 DING Zhiguo2

Cite this article:

XU Shoujing1 QI Shuo2 SHANG Jianwei3 HU Rui3 CHEN Xiaoheng3 YAO Simiao1 DING Zhiguo2. Distribution of clinical symptoms and syndrome in enthyroid Hashimoto thyroiditis patients[J]. 中国医药导报, 2022, 19(29): 134-138.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2022.29.31 OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I29/134

[1] 吕思颖，万辰，金熠婷，等.针药结合治疗桥本甲状腺炎的临床研究[C]//.新时代新思维新跨越新发展——2019中国针灸学会年会暨40周年回顾论文集.中国针灸学会会议论文集，2019：1240-1243.
[2] Li Y，Teng D，Ba J，et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders： Epidemiological Evidence from 31 Provinces of Mainland China [J]. Thyroid，2020，30（4）：568-579.
[3] 秦雅雯，郑敏，王之莹，等.中医药干预桥本甲状腺炎作用机制研究进展[J].四川中医，2021，39（7）：218-222.
[4] 李硕苗，林玮，侯建婷，等.基于聚类分析的桥本甲状腺炎中医证素分布规律[J].云南中医中药志，2021，42（8）：29-32.
[5] 章丽琼，邹碧君，陈清光，等.134例桥本甲状腺炎合并甲状腺结节患者的中医证候分布规律[J].世界中医药，2021，16（20）：3082-3085，3092.
[6] 任健瑜.桥本甲状腺炎的中医证候分布情况及用药规律分析[D].济南：山东中医药大学，2019.
[7] 魏亚威.桥本氏甲状腺炎的中医症状与甲状腺功能及自身抗体的关联规则研究[D].武汉：湖北中医药大学，2020.
[8] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺炎[J].中华内科杂志，2008，47（9）：784-788.
[9] 国家卫生健康委员会，国家中医药管理局.中医临床诊疗术语第2部分：证候（2020年修订版）[M].北京：中国标准出版社，2020.
[10] 邓铁涛.中医证候规范[M].广州：广东科技出版社，1989：203-213.
[11] 李振吉.中医药常用名词术语辞典[Ｍ].北京：中国中医药出版社，2001.
[12] 朱文峰.中医诊断学[M].北京：中国中医药出版社，2002.
[13] 赵佶.圣济总录[M].北京：中国中医药出版社，2018.
[14] 王楚媛，单忠艳.瘦素与自身免疫性甲状腺疾病[J].中国实用内科杂志，2019，39（6）：572-574.
[15] Merrill SJ，Mu Y. Thyroid autoimmunity as a window to autoimmunity： An explanation for the sex differences in the prevalence of thyroid autoimmunity [J]. J Theor Biol，2015，375：95-100.
[16] 程永红，韩梅，贾晓斌，等.外周血白细胞分化抗原195、雌二醇水平与桥本甲状腺炎相关性研究[J].陕西医学杂志，2020，49（11）：1461-1464.
[17] 巢元方.诸病源候论[M].北京：中国医药科技出版社，2011.
[18] 魏军平，赵静，孙士鹏，等.桥本甲状腺炎相关miRNAs研究进展[J].医学研究杂志，2019，48（4）：1-5，9.
[19] 王冰.黄帝内经素问[M].北京：人民卫生出版社，2014．
[20] 徐鑫利，李彦婷，姜珏，等.常规超声、弹性成像联合超声造影对桥本氏甲状腺炎背景下乳头状癌的诊断价值[J].临床超声医学杂志，2022，24（3）：219-222.
[21] Lai XJ，Xia Y，Zhang B，et al. A meta-analysis of Hashimoto’sthyroiditis and papillary thyroid carcinoma risk [J].Oncotarget，2017，8（37）：62414-62424.
[22] Ahn D，Heo SJ，Park JH，et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer [J]． Acta Oncol，2011，50（8）：1228-1234.
[23] Graceffa G，Patrone R，Vieni S，et al. Association between Hashimoto’s thyroiditis and papillary thyroid carcinoma： a retrospective analysis of 305 patients [J]. BMC Endocr Disord，2019，9（1）：26-27.
[24] 张景斌，王昱骄，李达，等.女性桥本甲状腺炎患者血清和甲状腺组织标志物检测的临床意义[J].中国妇幼健，2021，36（8）：1878-1881.
[25] 魏军平，赵静，孙士鹏，等.桥本甲状腺炎相关miRNAs研究进展[J].医学研究杂志，2019，48（4）：1-5，9.
[26] 张微，张明海，胡君.小金丸联合夏枯草胶囊治疗桥本甲状腺炎伴结节的效果及对炎症因子的影响[J].中国当代医药，2022，29（7）：78-81.
[27] 白春林，何涛，肖莉，等.金水宝胶囊联合左甲状腺素片治疗桥本甲状腺炎的效果及对过氧化物酶抗体和炎症因子的影响[J].中国医药导报，2020，17（22）：148-151.
[28] 丁治国.靥本相应论：甲状腺疾病中医诊疗新思路[M].北京：清华大学出版社，2021.